The dietary antioxidant network and prostate carcinoma

vidence from epidemiologic, clinical, and laboratory studies isgradually emerging supporting the concept that a complex inter-action between the host antioxidant defense system and dietary an-tioxidants may participate in the origin and progression of prostatecarcinoma. Although “antioxidant” hypotheses have long been pro-posed to underlie the development of many cancers,

[1]  J. Manson,et al.  β‐carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma , 1999, Cancer.

[2]  W. Fair,et al.  Vitamin E inhibits the high-fat diet promoted growth of established human prostate LNCaP tumors in nude mice. , 1999, The Journal of urology.

[3]  W. Willett,et al.  Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. , 1999, Cancer research.

[4]  E. Giovannucci,et al.  Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. , 1999, Journal of the National Cancer Institute.

[5]  H. Stähelin,et al.  Smoking, plasma vitamins C, E, retinol, and carotene, and fatal prostate cancer: Seventeen‐year follow‐up of the prospective Basel study , 1999, The Prostate.

[6]  S. Clinton,et al.  Lycopene: chemistry, biology, and implications for human health and disease. , 2009, Nutrition reviews.

[7]  E. Rimm,et al.  Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. , 1998, Journal of the National Cancer Institute.

[8]  D. Albanes,et al.  The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9]  S. Ripatti,et al.  Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. , 1998, Journal of the National Cancer Institute.

[10]  Bruce W. Turnbull,et al.  Effects of Selenium Supplementation for Cancer Prevention in Patients With Carcinoma of the Skin: A Randomized Controlled Trial , 1996 .

[11]  D. Bostwick,et al.  cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[12]  G. Omenn,et al.  Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. , 1996, The New England journal of medicine.

[13]  J. Manson,et al.  Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. , 1996, The New England journal of medicine.

[14]  B W Turnbull,et al.  Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. , 1996, JAMA.

[15]  G A Colditz,et al.  Intake of carotenoids and retinol in relation to risk of prostate cancer. , 1995, Journal of the National Cancer Institute.

[16]  D. Albanes,et al.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.

[17]  B. Ames,et al.  Oxidants, antioxidants, and the degenerative diseases of aging. , 1993, Proceedings of the National Academy of Sciences of the United States of America.